Aspirin and cancer: biological mechanisms and clinical outcomes.

Elwood, Peter; Protty, Majd; Morgan, Gareth; Pickering, Janet; Delon, Christine; Watkins, John

Elwood, Peter; Protty, Majd; Morgan, Gareth; Pickering, Janet; Delon, Christine; Watkins, John.

Afiliação

Elwood P; Division of Population Medicine, University of Cardiff, Cardiff, Wales CF10 3AT, UK.
Protty M; Department of Cardiology, Cardiff Lipidomic Group, University of Cardiff, Cardiff, Wales, UK.
Morgan G; Public Health Wales, Cardiff, Wales, UK.
Pickering J; Division of Population Medicine, University of Cardiff, Cardiff, Wales CF10 3AT, UK.
Delon C; Independent Research, London, England, UK.
Watkins J; Division of Population Medicine, University of Cardiff, Cardiff, Wales CF10 3AT, UK.

Open Biol ; 12(9): 220124, 2022 09.

Article em En | MEDLINE | ID: mdl-36099932

Assuntos

Doenças Cardiovasculares; Neoplasias; Aspirina/farmacologia; Aspirina/uso terapêutico; Doenças Cardiovasculares/tratamento farmacológico; Humanos; Neoplasias/tratamento farmacológico

Palavras-chave

aspirin; bleeding; cancer; survival; thromboembolism

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Neoplasias Tipo de estudo: Clinical_trials / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google